MORPHOSYS AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 66.2 EUR | +0.84% |
|
-2.29% | +94.71% |
| 04-30 | European Equities Traded in the US as American Depositary Receipts Decline | MT |
| 04-30 | MorphoSys AG Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 2.67B | - | |||||
| 42.19B | ||||||
| 40.15B | ||||||
| 28.31B | ||||||
| 24.63B | ||||||
| 18.2B | - |
- Stock Market
- Equities
- MOR Stock
- Charts MorphoSys AG
- Sector Chart
